Annual report pursuant to Section 13 and 15(d)

Note 8 - Accrued Liabilities

v3.24.1
Note 8 - Accrued Liabilities
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]

8.

Accrued Liabilities

 

Accrued liabilities consisted of the following (in thousands):

 

   

December 31, 2023

   

December 31, 2022

 

Accrued compensation

    766       667  

Accrued research and other professional fees

    730       215  

Accrued clinical trial costs

    258       472  

Accrued other liabilities

    23       11  

Total accrued liabilities

  $ 1,777     $ 1,365